Total Raised
$24.3MInvestors Count
8Deal Terms
2Funding, Valuation & Revenue
4 Fundings
Scion Pharmaceuticals's latest funding round was a Series B for $17.5M on July 24, 2002.
Scion Pharmaceuticals's valuation in November 2001 was $14.09M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
7/24/2002 | Series B | $17.5M | ||||
11/13/2001 | Series A | $14.09M | ||||
9/7/2001 | Seed VC - II | |||||
4/1/2001 | Seed |
Date | 7/24/2002 | 11/13/2001 | 9/7/2001 | 4/1/2001 |
|---|---|---|---|---|
Round | Series B | Series A | Seed VC - II | Seed |
Amount | $17.5M | |||
Investors | ||||
Valuation | $14.09M | |||
Revenue | ||||
Sources |
This profile has not been claimed.
You're more than your latest funding, tell our customers your company's story.
Scion Pharmaceuticals Deal Terms
2 Deal Terms
Scion Pharmaceuticals's deal structure is available for 2 funding rounds, including their Series B from July 24, 2002.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Scion Pharmaceuticals Investors
8 Investors
Scion Pharmaceuticals has 8 investors. Oxford Bioscience Partners invested in Scion Pharmaceuticals's Seed VC - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
9/7/2001 | 7/24/2002 | 3 Series A, Series B (2002), Seed VC - II (2001) | Venture Capital | Massachusetts | ||
Venture Capital | Netherlands | |||||
Private Equity | Canada | |||||
Venture Capital | Pennsylvania | |||||
Venture Capital | Pennsylvania |
First funding | 9/7/2001 | ||||
|---|---|---|---|---|---|
Last Funding | 7/24/2002 | ||||
Investor | |||||
Rounds | 3 Series A, Series B (2002), Seed VC - II (2001) | ||||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Private Equity | Venture Capital | Venture Capital |
Location | Massachusetts | Netherlands | Canada | Pennsylvania | Pennsylvania |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.